Patients struggle to get weight loss drug ahead of price rise

Date:

Some patients taking the weight-loss drug Mounjaro have told BBC News they are struggling to obtain the medicine, and are worried about the impact on their health.

There is rising demand for the drug, after the US manufacturer Eli Lilly announced a major price increase from 1 September.

The drug giant has warned against “inappropriate stockpiling of medicines” and has now asked UK distributors to stop taking orders from pharmacies from the end of today.

Pharmacies say they are prioritising patients already taking the drug, rather than those just starting it, and predict supplies will return to normal in early September.

Lynne Massey-Davis, 65, from East Yorkshire, says trying to find Mounjaro stock has been “stressful” after her last prescription order with an online provider wasn’t delivered.

“I’m in a holding queue,” she said. “It’s a very uncertain time. I’ve spent a lot of time on the phone.”

She’s been told there will be a two-week…

Read more…

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Tampa RV giant Lazydays to delist from Nasdaq

Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...

Granite Geek: New Hampshire might get access to ‘balcony solar’

I had solar panels put on my roof six...

TSX Today: What to Watch for in Stocks on Monday, November 10

Despite firm gold and silver prices, Canadian stocks...

While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!

As market-wide fear grips the sector, the Binance Coin...